76 completed. 76 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 76 | Completed 76 |
Follow Mycoses: new trials by email Literature Review of Mycoses trials Research Report on Mycoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Self Vs. Physician Application of Triamcinolone-Econazole in Otomycosis physician-applied Triamcinolone Acetonide Econazole Cream, patient-applied Triamcinolone Acetonide Econazole Cream - Otomycosis | Phase 4 | Completed | Zhongshan Hospital Xiamen University | 200 | 2024-06-01 | 2024-11-01 |
| 8% Sulphur-Aloe Vera Soap as an Adjuvant Treatment for Pityriasis Versicolor 8% sulphur and A. vera soap - Pityriasis Versicolor | Phase 4 | Completed | Universitas Padjadjaran | 42 | 2023-08-25 | 2024-03-26 |
| Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi Isavuconazole - Invasive Fungal Disease | Phase 4 | Completed | Pfizer | 70 | 2023-02-07 | 2026-05-27 |
| Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection Micafungin, Amphotericin B - Neonatal Infection, Invasive Fungal Infections | Phase 4 | Completed | Ain Shams University | 56 | 2022-10-20 | 2024-05-16 |
| Evaluate Bioequivalence of Micafungin (50mg/Vial) Micafungin - Invasive Candidiasis | Phase 4 | Completed | Yung Shin Pharm. Ind. Co., Ltd. | 14 | 2022-01-06 | 2022-08-11 |
| Study of Lactobacillus in Adjuvant Treatment of RVVC clotrimazole vaginal tablets, Clotrimazole vaginal tablets+ Lactobacillus - Recurrent Vulvovaginal Candidiasis | Phase 4 | Completed | Peking University Shenzhen Hospital | 140 | 2020-07-01 | 2025-06-12 |
| Itraconazole Oral Absorption fast itraconazole tablet, medium itraconazole tablet, slow itraconazole tablet - Fungal Infection | Phase 4 | Completed | University of Maryland, Baltimore | 17 | 2020-02-10 | 2023-10-05 |
| Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration Fluconazole 200mg tab, Fluconazole 2 MG/ML - Fluconazole, Candidiasis | Phase 4 | Completed | Radboud University Medical Center | 25 | 2019-11-30 | 2021-07-14 |
| Evaluation of Efficacy and Safety of Gynomax® XL Ovule Gynomax® XL Vaginal Ovule - Trichomonal Vaginitis, Bacterial Vaginosis | Phase 4 | Completed | Exeltis Turkey | 116 | 2019-04-03 | 2020-01-31 |
| Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis amphotericin B in 30% DMSO, 30% DMSO - Fungal Infection, Onychomycosis | Phase 4 | Completed | Mahidol University | 19 | 2019-01-15 | 2021-09-28 |
| The Comparative Assessment of Mycological Efficacy, Safety, Recurrence, and Cost-effectiveness of Selenium Sulfide 1.8% Shampoo Versus Ketoconazole 2% Shampoo in Pityriasis Versicolor: a Double-blind Randomized Controlled Trial shampoo with different composition - Pityriasis Versicolor | Phase 4 | Completed | Universitas Indonesia | 100 | 2018-09-01 | 2019-07-05 |
| CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels Voriconazole genotype-specific dosing, Standard of Care - Aspergillosis Invasive, Fungal Infection | Phase 4 | Completed | University Health Network, Toronto | 30 | 2018-01-10 | 2020-11-03 |
| Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients SOC +Posaconazole 18 MG/ML (milligram/milliliter), standard of care (SOC) - Aspergillosis; Pulmonary, Invasive (Etiology) | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 88 | 2017-12-27 | 2025-04-08 |
| Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis Jublia® - Mild to Moderate Onychomycosis Due to Dermatophyte | Phase 4 | Completed | Dong-A ST Co., Ltd. | 97 | 2017-11-10 | 2021-04-27 |
| Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria Cotrimoxazole, Placebo - HIV-1-infection, Pneumocystis Pneumonia | Phase 4 | Completed | University of Bergen | 537 | 2017-03-30 | 2019-10-02 |
| Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis Efinaconazole - Onychomycosis | Phase 4 | Completed | Bausch Health Americas, Inc. | 62 | 2016-08-04 | 2021-11-01 |
| Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte Onychomycosis 1,064nm Long-pulsed Nd:YAG, Amorolfine - Non-dermatophyte Onychomycosis | Phase 4 | Completed | Mahidol University | 60 | 2016-08-01 | 2021-09-28 |
| Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections Boric acid and probiotics, Antibiotic (Clindamycin), Antifungal (Clotrimazole) - Candidiasis, Vaginosis, Bacterial | Phase 4 | Completed | Laboratorios Ordesa | 48 | 2016-07-12 | 2019-11-19 |
| Pharmacokinetics of Two Different Formulation of Voriconazole Vaway FC Tablets 200mg (Voriconazole), VFEND FC Tablets 200mg (Voriconazole) - Fungus Infection | Phase 4 | Completed | Yung Shin Pharm. Ind. Co., Ltd. | 29 | 2016-06-01 | 2016-09-23 |
| Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis Luliconazole Cream 1%, Vehicle Cream - Tinea Corporis | Phase 4 | Completed | Bausch Health Americas, Inc. | 75 | 2016-02-08 | 2019-11-27 |
Showing 20 of 76. Sign in to see all of them.
Onychomycosis (13) · Candidiasis (10) · Candidiasis, Vulvovaginal (7) · Candidemia (6) · Candidiasis, Invasive (6) · Invasive Fungal Infections (6) · Acquired Immunodeficiency Syndrome (4) · Aspergillosis (4) · HIV Infections (4) · Obesity (4) · Tinea (4) · Candidiasis, Oral (3) · Cryptococcosis (3) · Foot Dermatoses (3)
Bacterial Infections and Mycoses (76) · Infections (76) · Dermatomycoses (23) · Skin Diseases (23) · Skin Diseases, Infectious (23) · Skin and Connective Tissue Diseases (23) · Pathological Conditions, Signs and Symptoms (17) · Urogenital Diseases (17) · Candidiasis (16) · Genital Diseases (15) · Tinea (15) · Nail Diseases (13) · Female Urogenital Diseases and Pregnancy Complications (11) · Invasive Fungal Infections (11)
Fluconazole (9) · Voriconazole (9) · Anidulafungin (7) · Itraconazole (5) · Micafungin (5) · Clotrimazole (4) · Caspofungin (3) · Solutions (3) · efinaconazole (3) · liposomal amphotericin B (3) · Amphotericin B (2) · Clindamycin (2) · Miconazole (2) · Standard of Care (2) · Trimethoprim, Sulfamethoxazole Drug Combination (2)
Pfizer (9) · National Institute of Allergy and Infectious Diseases (NIAID) (4) · Bausch Health Americas, Inc. (3) · Galderma R&D (3) · Mahidol University (3) · Merz North America, Inc. (3) · Peking University Shenzhen Hospital (3) · Texas Tech University Health Sciences Center (2) · University of Minnesota (2) · Yung Shin Pharm. Ind. Co., Ltd. (2) · Ain Shams University (1) · Allergy & Asthma Medical Group & Research Center (1) · Bausch & Lomb Incorporated (1) · Boni Elewski, MD (1) · Botswana-UPenn Partnership (1)
United States (26) · China (8) · Dominican Republic (6) · Honduras (5) · Spain (4) · Thailand (4) · Brazil (3) · France (3) · Puerto Rico (3) · South Korea (3) · Belgium (2) · Germany (2) · Iceland (2) · India (2) · Indonesia (2)
Anya Loncaric (3) · Shangrong Fan, M.D. (3) · Alan Fleischer, MD (2) · Boni E Elewski, MD (2) · Ronald Hall, PharmD, MSCS (2) · Alan B. Fleischer, MD (1) · Asuncion Moreno, MD (1) · Bharti R Daswani, MD, PhD (1) · Binu Alexander, MD (1) · Carlos Cervera, MD (1) · Charussri Leeyaphan, MD (1) · Chun Wang, M.D. (1)
PMID 28459966, PMID 28597967, PMID 31280481, PMID 33891293, PMID 10233295, PMID 10642676, PMID 14723731, PMID 19144094, PMID 20347657, PMID 21319349, PMID 21820203, PMID 22236569, PMID 22290953, PMID 22490643, PMID 22976905, PMID 23278851, PMID 23362285, PMID 23416171, PMID 23459494, PMID 23496375, PMID 23710653, PMID 23939898, PMID 24079583, PMID 24550378, PMID 24559321, PMID 24963568, PMID 25013957, PMID 25376267, PMID 25639524, PMID 25877666, PMID 26050015, PMID 26392095, PMID 26471716, PMID 27073145, PMID 27287231, PMID 27799043, PMID 27815659, PMID 30325463, PMID 30399034, PMID 30811142, PMID 31319498, PMID 31367384, PMID 31504335, PMID 32653726, PMID 32843994, PMID 32940765, PMID 33586013, PMID 34050768, PMID 36803640, PMID 38828958
5UL1RR024982-02 (2), 2015 (1), U01AI089244 (1), U01GH000517 (1)